Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 23;21(1):119.
doi: 10.3390/ijms21010119.

Amino Acid Transport Defects in Human Inherited Metabolic Disorders

Affiliations
Review

Amino Acid Transport Defects in Human Inherited Metabolic Disorders

Raquel Yahyaoui et al. Int J Mol Sci. .

Abstract

Amino acid transporters play very important roles in nutrient uptake, neurotransmitter recycling, protein synthesis, gene expression, cell redox balance, cell signaling, and regulation of cell volume. With regard to transporters that are closely connected to metabolism, amino acid transporter-associated diseases are linked to metabolic disorders, particularly when they involve different organs, cell types, or cell compartments. To date, 65 different human solute carrier (SLC) families and more than 400 transporter genes have been identified, including 11 that are known to include amino acid transporters. This review intends to summarize and update all the conditions in which a strong association has been found between an amino acid transporter and an inherited metabolic disorder. Many of these inherited disorders have been identified in recent years. In this work, the physiological functions of amino acid transporters will be described by the inherited diseases that arise from transporter impairment. The pathogenesis, clinical phenotype, laboratory findings, diagnosis, genetics, and treatment of these disorders are also briefly described. Appropriate clinical and diagnostic characterization of the underlying molecular defect may give patients the opportunity to avail themselves of appropriate therapeutic options in the future.

Keywords: SLC; amino acid transporter; inborn errors of metabolism; inherited metabolic disorders; membrane transport; solute carriers; symporter.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Bröer S., Bröer A. Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem. J. 2017;474:1935–1963. doi: 10.1042/BCJ20160822. - DOI - PMC - PubMed
    1. Schweikhard E.S., Ziegler C.M. Amino acid secondary transporters: Toward a common transport mechanism. Curr. Top. Membr. 2012;70:1–28. - PubMed
    1. Wong F.H., Chen J.S., Reddy V., Day J.L., Shlykov M.A., Wakabayashi S.T., Sailer M.H., Jr. The amino Acid-polyamine-organocation superfamily. J. Mol. Microbiol. Biotechnol. 2012;22:105–113. doi: 10.1159/000338542. - DOI - PubMed
    1. Verrey F., Singer D., Ramadan T., Vuille-dit-Bille R.N., Mariotta L., Camargo S.M. Kidney amino acid transport. Pflugers Arch. 2009;458:53–60. doi: 10.1007/s00424-009-0638-2. - DOI - PubMed
    1. Palacin M., Estevez R., Bertran J., Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 1998;78:969–1054. doi: 10.1152/physrev.1998.78.4.969. - DOI - PubMed

MeSH terms